Search

NIAID-Funded Adjuvant Improves Typhoid Vaccine Candidate in Animal

4.6 (265) · $ 12.50 · In stock

NIAID-Funded Adjuvant Improves Typhoid Vaccine Candidate in Animal

An investigational typhoid vaccine containing a component developed with NIAID funding may overcome some of the shortcomings of available typhoid vaccines, according to a paper published in the journal Vaccine in June.

Vaccines platforms and COVID-19: what you need to know

Vaccines platforms and COVID-19: what you need to know

Nanocarrier vaccines for SARS-CoV-2 - ScienceDirect

Nanocarrier vaccines for SARS-CoV-2 - ScienceDirect

Transcriptional correlates of malaria in RTS,S/AS01-vaccinated

Transcriptional correlates of malaria in RTS,S/AS01-vaccinated

Emerging concepts in the science of vaccine adjuvants

Emerging concepts in the science of vaccine adjuvants

PDF) Vaccine Strategies to Elicit Mucosal Immunity

PDF) Vaccine Strategies to Elicit Mucosal Immunity

The Role of Vaccines in Combating Antimicrobial Resistance

The Role of Vaccines in Combating Antimicrobial Resistance

Frontiers  Polyphosphazenes as Adjuvants for Animal Vaccines and

Frontiers Polyphosphazenes as Adjuvants for Animal Vaccines and

Vaccines, Free Full-Text

Vaccines, Free Full-Text

Frontiers  U-Omp19 from Brucella abortus Is a Useful Adjuvant for

Frontiers U-Omp19 from Brucella abortus Is a Useful Adjuvant for

Malaria transmission-blocking conjugate vaccine in ALFQ adjuvant

Malaria transmission-blocking conjugate vaccine in ALFQ adjuvant

Frontiers  Progress and Pitfalls in the Quest for Effective SARS

Frontiers Progress and Pitfalls in the Quest for Effective SARS

News - VaccineNation

News - VaccineNation